{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:32:46Z","timestamp":1774121566061,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T00:00:00Z","timestamp":1199318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T00:00:00Z","timestamp":1199318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12016-007-8057-7","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T15:36:55Z","timestamp":1199288215000},"page":"372-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["B-Cell Depletion in Wegener\u2019s Granulomatosis"],"prefix":"10.1007","volume":"34","author":[{"given":"Claas H.","family":"Hinze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Colbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,3]]},"reference":[{"key":"8057_CR1","first-page":"455","volume":"42","author":"H Klinger","year":"1931","unstructured":"Klinger H (1931) Grenzformen der Periarteritis nodosa. Frankf Z Pathol 42:455\u2013480","journal-title":"Frankf Z Pathol"},{"key":"8057_CR2","first-page":"36","volume":"109","author":"F Wegener","year":"1939","unstructured":"Wegener F (1939) \u00dcber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol Anat 109:36\u201368","journal-title":"Beitr Pathol Anat"},{"issue":"8","key":"8057_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","volume":"46","author":"AJ Mohammad","year":"2007","unstructured":"Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener\u2019s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46(8):1329\u20131337","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8057_CR4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-67-2-393","volume":"67","author":"D Hollander","year":"1967","unstructured":"Hollander D, Manning RT (1967) The use of alkylating agents in the treatment of Wegener\u2019s granulomatosis. Ann Intern Med 67(2):393\u2013398","journal-title":"Ann Intern Med"},{"issue":"6","key":"8057_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488\u2013498","journal-title":"Ann Intern Med"},{"issue":"8426","key":"8057_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","volume":"1","author":"FJ van der Woude","year":"1985","unstructured":"van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis. Lancet 1(8426):425\u2013429","journal-title":"Lancet"},{"issue":"9533","key":"8057_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","volume":"368","author":"X Bosch","year":"2006","unstructured":"Bosch X, Guilabert A, Font J (2006) Antineutrophil cytoplasmic antibodies. Lancet 368(9533):404\u2013418","journal-title":"Lancet"},{"issue":"9","key":"8057_CR8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","volume":"41","author":"GS Hoffman","year":"1998","unstructured":"Hoffman GS, Specks U (1998) Antineutrophil cytoplasmic antibodies. Arthritis Rheum 41(9):1521\u20131537","journal-title":"Arthritis Rheum"},{"issue":"11","key":"8057_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/ard.59.11.898","volume":"59","author":"H Locht","year":"2000","unstructured":"Locht H, Skogh T, Wiik A (2000) Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis. Ann Rheum Dis 59(11):898\u2013903","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8057_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.amjmed.2006.08.016","volume":"120","author":"JD Finkielman","year":"2007","unstructured":"Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA et al (2007) ANCA are detectable in nearly all patients with active severe Wegener\u2019s granulomatosis. Am J Med 120(7):643, e9\u2013e14","journal-title":"Am J Med"},{"issue":"9","key":"8057_CR11","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","volume":"43","author":"MM Boomsma","year":"2000","unstructured":"Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG et al (2000) Prediction of relapses in Wegener\u2019s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43(9):2025\u20132033","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8057_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","volume":"45","author":"DJ Schlieben","year":"2005","unstructured":"Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ (2005) Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 45(4):758\u2013761","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"8057_CR13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110(7):955\u2013963","journal-title":"J Clin Invest"},{"issue":"3","key":"8057_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1568-9972(03)00010-7","volume":"2","author":"E Csernok","year":"2003","unstructured":"Csernok E (2003) Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2(3):158\u2013164","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8057_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1189\/jlb.1202611","volume":"74","author":"AA Rarok","year":"2003","unstructured":"Rarok AA, Limburg PC, Kallenberg CG (2003) Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74(1):3\u201315","journal-title":"J Leukoc Biol"},{"issue":"4","key":"8057_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/art.20534","volume":"51","author":"D Albert","year":"2004","unstructured":"Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA (2004) Wegener\u2019s granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum 51(4):656\u2013664","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8057_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","volume":"120","author":"CA Stegeman","year":"1994","unstructured":"Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120(1):12\u201317","journal-title":"Ann Intern Med"},{"issue":"1","key":"8057_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJM199607043350103","volume":"335","author":"CA Stegeman","year":"1996","unstructured":"Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG (1996) Trimethoprim-sulfamethoxazole (cotrimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 335(1):16\u201320","journal-title":"N Engl J Med"},{"issue":"4","key":"8057_CR19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","volume":"42","author":"E Csernok","year":"1999","unstructured":"Csernok E, Trabandt A, Muller A, Wang GC, Moosig F, Paulsen J et al (1999) Cytokine profiles in Wegener\u2019s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 42(4):742\u2013750","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8057_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/adpa.2002.35752","volume":"6","author":"DK Heffner","year":"2002","unstructured":"Heffner DK (2002) Wegener\u2019s granulomatosis is not a granulomatous disease. Ann Diagn Pathol 6(5):329\u2013333","journal-title":"Ann Diagn Pathol"},{"issue":"7","key":"8057_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/ard.2005.044909","volume":"65","author":"J Voswinkel","year":"2006","unstructured":"Voswinkel J, Mueller A, Kraemer JA, Lamprecht P, Herlyn K, Holl-Ulrich K et al (2006) B lymphocyte maturation in Wegener\u2019s granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 65(7):859\u2013864","journal-title":"Ann Rheum Dis"},{"issue":"2\u20133","key":"8057_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2007.02.011","volume":"28","author":"P Youinou","year":"2007","unstructured":"Youinou P (2007) B cell conducts the lymphocyte orchestra. J Autoimmun 28(2\u20133):143\u2013151","journal-title":"J Autoimmun"},{"issue":"4","key":"8057_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","volume":"25","author":"M Krumbholz","year":"2005","unstructured":"Krumbholz M, Specks U, Wick M, Kalled SL, Jenne D, Meinl E (2005) BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis. J Autoimmun 25(4):298\u2013302","journal-title":"J Autoimmun"},{"issue":"5","key":"8057_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.autrev.2004.02.001","volume":"3","author":"KP Baker","year":"2004","unstructured":"Baker KP (2004) BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun Rev 3(5):368\u2013375","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8057_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.autrev.2007.02.004","volume":"6","author":"F Atzeni","year":"2007","unstructured":"Atzeni F, Doria A, Maurizio T, Sarzi-Puttini P (2007) What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimmun Rev 6(8):553\u2013558","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8057_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.autrev.2005.05.006","volume":"5","author":"A Thatayatikom","year":"2006","unstructured":"Thatayatikom A, White AJ (2006) Rituximab: a promising therapy in systemic lupus erythematosus. Autoimmun Rev 5(1):18\u201324","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8057_CR27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44(6):1313\u20131319","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8057_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1182\/blood-2004-02-0564","volume":"105","author":"P Scapini","year":"2005","unstructured":"Scapini P, Carletto A, Nardelli B, Calzetti F, Roschke V, Merigo F et al (2005) Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases. Blood 105(2):830\u2013837","journal-title":"Blood"},{"issue":"5","key":"8057_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1055\/s-2004-836143","volume":"25","author":"JP Lynch 3rd","year":"2004","unstructured":"Lynch JP 3rd, White E, Tazelaar H, Langford CA (2004) Wegener\u2019s granulomatosis: evolving concepts in treatment. Semin Respir Crit Care Med 25(5):491\u2013521","journal-title":"Semin Respir Crit Care Med"},{"issue":"12","key":"8057_CR30","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E","volume":"42","author":"CA Langford","year":"1999","unstructured":"Langford CA, Talar-Williams C, Barron KS, Sneller MC (1999) A staged approach to the treatment of Wegener\u2019s granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 42(12):2666\u20132673","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8057_CR31","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/art.21146","volume":"52","author":"U Specks","year":"2005","unstructured":"Specks U (2005) Methotrexate for Wegener\u2019s granulomatosis: what is the evidence? Arthritis Rheum 52(8):2237\u20132242","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8057_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36\u201344","journal-title":"N Engl J Med"},{"issue":"5","key":"8057_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS (2001) Etanercept combined with conventional treatment in Wegener\u2019s granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 44(5):1149\u20131154","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8057_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"The Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","unstructured":"The Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352(4):351\u2013361","journal-title":"N Engl J Med"},{"issue":"12","key":"8057_CR35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/qjmed\/89.12.903","volume":"89","author":"CM Lockwood","year":"1996","unstructured":"Lockwood CM, Thiru S, Stewart S, Hale G, Isaacs J, Wraight P et al (1996) Treatment of refractory Wegener\u2019s granulomatosis with humanized monoclonal antibodies. QJM 89(12):903\u2013912","journal-title":"QJM"},{"issue":"4","key":"8057_CR36","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","volume":"65","author":"WH Schmitt","year":"2004","unstructured":"Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ (2004) Treatment of refractory Wegener\u2019s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 65(4):1440\u20131448","journal-title":"Kidney Int"},{"issue":"6","key":"8057_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","volume":"42","author":"PJ Klemmer","year":"2003","unstructured":"Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42(6):1149\u20131153","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"8057_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.20717","volume":"52","author":"MC Sneller","year":"2005","unstructured":"Sneller MC (2005) Rituximab and Wegener\u2019s granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum 52(1):1\u20135","journal-title":"Arthritis Rheum"},{"issue":"25","key":"8057_CR39","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1056\/NEJMp048114","volume":"350","author":"GC Tsokos","year":"2004","unstructured":"Tsokos GC (2004) B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis. N Engl J Med 350(25):2546\u20132548","journal-title":"N Engl J Med"},{"issue":"7","key":"8057_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.autrev.2005.03.002","volume":"4","author":"M Pitashny","year":"2005","unstructured":"Pitashny M, Shoenfeld Y (2005) B cell depletion in autoimmune rheumatic diseases. Autoimmun Rev 4(7):436\u2013441","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8057_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.autrev.2005.04.004","volume":"4","author":"F Perosa","year":"2005","unstructured":"Perosa F, Favoino E, Caragnano MA, Prete M, Dammacco F (2005) CD20: a target antigen for immunotherapy of autoimmune diseases. Autoimmun Rev 4(8):526\u2013531","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8057_CR42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"ME Reff","year":"1994","unstructured":"Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R et al (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83(2):435\u2013445","journal-title":"Blood"},{"issue":"4","key":"8057_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jpeds.2006.12.050","volume":"150","author":"CH Hinze","year":"2007","unstructured":"Hinze CH, Grom AA (2007) B cell depletion: on the rise. J Pediatr 150(4):335\u2013337","journal-title":"J Pediatr"},{"issue":"2","key":"8057_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/art.21617","volume":"54","author":"MJ Leandro","year":"2006","unstructured":"Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC (2006) Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 54(2):613\u2013620","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8057_CR45","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/rheumatology\/kel393","volume":"46","author":"C Popa","year":"2007","unstructured":"Popa C, Leandro MJ, Cambridge G, Edwards JC (2007) Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs. Rheumatology (Oxford) 46(4):626\u2013630","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8057_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/art.20718","volume":"52","author":"KA Keogh","year":"2005","unstructured":"Keogh KA, Wylam ME, Stone JH, Specks U (2005) Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(1):262\u2013268","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8057_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/02813430510015269","volume":"34","author":"R Omdal","year":"2005","unstructured":"Omdal R, Wildhagen K, Hansen T, Gunnarsson R, Kristoffersen G (2005) Anti-CD20 therapy of treatment-resistant Wegener\u2019s granulomatosis: favourable but temporary response. Scand J Rheumatol 34(3):229\u2013232","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"8057_CR48","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/ndt\/gfh599","volume":"20","author":"AJ Ferraro","year":"2005","unstructured":"Ferraro AJ, Day CJ, Drayson MT, Savage CO (2005) Effective therapeutic use of rituximab in refractory Wegener\u2019s granulomatosis. Nephrol Dial Transplant 20(3):622\u2013625","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"8057_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","volume":"173","author":"KA Keogh","year":"2006","unstructured":"Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U (2006) Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173(2):180\u2013187","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"8057_CR50","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","volume":"45","author":"R Stasi","year":"2006","unstructured":"Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D (2006) Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 45(11):1432\u20131436","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"8057_CR51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/ard.2005.044487","volume":"65","author":"KP Ng","year":"2006","unstructured":"Ng KP, Leandro MJ, Edwards JC, Ehrenstein MR, Cambridge G, Isenberg DA (2006) Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. Ann Rheum Dis 65(7):942\u2013945","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8057_CR52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/ard.2005.044420","volume":"65","author":"PM Aries","year":"2006","unstructured":"Aries PM, Hellmich B, Voswinkel J, Both M, Nolle B, Holl-Ulrich K et al (2006) Lack of efficacy of rituximab in Wegener\u2019s granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 65(7):853\u2013858","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8057_CR53","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","volume":"31","author":"E Kimby","year":"2005","unstructured":"Kimby E (2005) Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31(6):456\u2013473","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"8057_CR54","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","volume":"107","author":"CM Bennett","year":"2006","unstructured":"Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC et al (2006) Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 107(7):2639\u20132642","journal-title":"Blood"},{"issue":"2","key":"8057_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/ard.2006.061002","volume":"66","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR et al (2007) Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 66(2):143\u2013150","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8057_CR56","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1002\/art.20592","volume":"50","author":"JH Anolik","year":"2004","unstructured":"Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ et al (2004) Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50(11):3580\u20133590","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8057_CR57","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/ard.2006.060772","volume":"66","author":"F Lavie","year":"2007","unstructured":"Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X (2007) Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann Rheum Dis 66(5):700\u2013703","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8057_CR58","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/ar2076","volume":"8","author":"T Vallerskog","year":"2006","unstructured":"Vallerskog T, Heimburger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C et al (2006) Differential effects on BAFF and APRIL levels in rituximab treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 8(6):R167","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-007-8057-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8057-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:05:40Z","timestamp":1659092740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-007-8057-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["8057"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8057-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,3]]},"assertion":[{"value":"3 January 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}